Home > Insider Trading > Filing (0001179110-19-000808)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1446159	Precision Therapeutics Inc.	AIPT	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	331007393

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1573354	I. Carl Schwartz	3750 Las Vegas Blvd. South Apt. 4303 Las Vegas NV 89158	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-01-08	78,125	$0.64	144,298	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (right to buy)	Acquisiton	2019-01-02	323,050	$0.00	323,050	$0.62
Common Stock	Amended and Restated Warrant to purchase common stock	Acquisiton	2019-01-08	742,188	$0.00	742,188	$0.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
323,050		2029-01-02	No	4	A	Direct
963,480	2019-07-08	2024-01-08	No	4	P	Direct

Footnotes

53,841 shares vest on each of 1/2/2019, 2/1/2019, 3/1/2019, 4/1/2019 and 5/1/2019; 53,845 shares vest on 6/1/2019.
Held by Carl I. Schwartz Revocable Living Trust.
This Amended and Restated Warrant (the "Warrant") amends and restates that certain warrant issued on November 30, 2018 (the "Original Warrant"), due to a second investment of an additional $950,000, resulting in a total investment of $1,320,000. (See Form 4 filed on December 10, 2018 for details of the Original Warrant.) In addition to the shares reported, the Warrant provides for additional shares to be added to the Warrant beginning on February 1, 2019 and the first day of each calendar month thereafter, equal to (1) one-half percent (1/2%) of the outstanding principal balance of the Note on such date, divided by (2) the closing price of Common Stock on that date. The number of warrant shares is subject to a share limit such that the total of number of warrant shares issued under the Warrant, together with the 78,125 shares purchased directly, may not exceed 2,818,350 shares.